在婴儿期早期,索塔洛尔的预防有效且安全地预防了心室上性心力衰竭
Caroline Evertsson1, Håkan Eliasson2,3, Cecilia Pegelow Halvorsen1,4
1Sachs' Children and Youth Hospital, Stockholm South General Hospital (Södersjukhuset), Stockholm, Sweden.
Acta paediatrica (Oslo, Norway : 1992)
|July 29, 2024
概括
索塔洛尔是一种有效和安全的预防,用于婴儿脑顶层心跳动 (SVT). 这项研究发现,在极小的QTc延长和没有前节律失常的情况下,成功率很高,这支持其在儿科心脏病学中的应用.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 电子生理学 电子生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 婴儿期上心室性心跳动 (SVT) 缺乏关于最佳预防治疗的共识.
- 索塔醇是一种β-阻断剂和III类抗失律剂,具有潜在的SVT预防作用.
研究的目的:
- 评估索塔醇作为婴儿SVT的预防剂的疗效和安全性.
- 评估治疗结果,包括成功率和不良事件,如QTc延长和前节律失常.
主要方法:
- 对85名被诊断患有SVT的婴儿进行了回顾性分析,这些婴儿在1岁之前接受了sotalol (2002-2018) 治疗.
- 收集的数据包括患者特征,并发症,索塔洛尔剂量,QT间隔和临床结果.
- 统计分析比较了产后与胎儿初出生的婴儿之间的成功率.
主要成果:
- 索塔洛尔的疗效很高,在67/75名完成治疗的患者中,成功预防,包括那些患有复发性心力衰竭的患者.
- 产后首次出现的婴儿与胎儿首次出现的婴儿 (78%) 相比,成功率显著更高 (96%).
- 16%的患者出现了QTc间隔延长,只有两个需要改变治疗;没有观察到前节律失常.
结论:
- 索塔是一种有效和安全的预防性治疗婴儿群体中SVT.
- QTc延长是一种罕见的副作用,很少需要停止治疗,而前节律失常并不是一个重大问题.
相关概念视频
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
727
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
727
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
812
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
812
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
952
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
952
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
429
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
429
01:28Disturbances in Heart Rhythm
927
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
927